Since the leukemia cell line K-562 was chemosensitive for both aurora kinase inhibitors (GW809897X and GW806742X), we decided to measure the AURKA and AURKB mRNA expression in the ALL patient’s blood cells. The gene discussed is AURKA; the disease is acute lymphoblastic leukemia.